Pengyuan Wang

Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial

Xudong Zhang, Qiming Wang, Tianjiang Ma, 2021, Translational lung cancer research.

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients

Xiao-yan Feng, Xudong Zhang, M. Dong, 2023, Cancer medicine.